Literature DB >> 17296144

Biomechanical evaluation of primary stiffness of tibiotalocalcaneal fusion with intramedullary nails.

Thomas Mückley1, Stephan Eichorn, Konrad Hoffmeier, Geert von Oldenburg, Andreas Speitling, Gunther O Hoffmann, Volker Bühren.   

Abstract

BACKGROUND: Intramedullary implants are being used with increasing frequency for tibiotalocalcaneal fusion (TTCF). Clinically, the question arises whether intramedullary (IM) nails should have a compression mode to enhance biomechanical stiffness and fusion-site compression. This biomechanical study compared the primary stability of TTCF constructs using compressed and uncompressed retrograde IM nails and a screw technique in a bone model.
METHODS: For each technique, three composite bone models were used. The implants were a Biomet nail (static locking mode and compressed mode), a T2 femoral nail (compressed mode); a prototype IM nail 1 (PT1, compressed mode), a prototype IM nail 2 (PT2, dynamic locking mode and compressed mode), and a three-screw construct. The compressed contact surface of each construct was measured with pressure-sensitive film and expressed as percent of the available fusion-site area. Stiffness was tested in dorsiflexion and plantarflexion (D/P), varus and valgus (V/V), and internal rotation and external rotation (I/E) (20 load cycles per loading mode).
RESULTS: Mean contact surfaces were 84.0 +/- 6.0% for the Biomet nail, 84.0 +/- 13.0% for the T2 nail, 70.0 +/- 7.2% for the PTI nail, and 83.5 +/- 5.5% for the compressed PT2 nail. The greatest primary stiffness in D/P was obtained with the compressed PT2, followed by the compressed Biomet nail. The dynamically locked PT2 produced the least primary stiffness. In V/V, PT1 had the (significantly) greatest primary stiffness, followed by the compressed PT2. The statically locked Biomet nail and the dynamically locked PT2 had the least primary stiffness in V/V. In I/E, the compressed PT2 had the greatest primary stiffness, followed by the PT1 and the T2 nails, which did not differ significantly from each other. The dynamically locked PT2 produced the least primary stiffness. The screw construct's contact surface and stiffness were intermediate.
CONCLUSIONS: The IM nails with compression used for TTCF produced good contact surfaces and primary stiffness. They were significantly superior in these respects to the uncompressed nails and the screw construct. The large contact surfaces and great primary stiffness provided by the IM nails in a bone model may translate into improved union rates in patients who have TTCF.

Entities:  

Mesh:

Year:  2007        PMID: 17296144     DOI: 10.3113/FAI.2007.0224

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  5 in total

1.  [Plantar approach to hindfoot arthrodesis with compressed angle stable locking option].

Authors:  T Mückley
Journal:  Unfallchirurg       Date:  2015-04       Impact factor: 1.000

Review 2.  [Arthroscopic tibiotalocalcaneal arthrodesis].

Authors:  S F Baumbach; M Braunstein; F Maßen; M Regauer; W Mutschler; W Böcker; H Polzer
Journal:  Unfallchirurg       Date:  2016-02       Impact factor: 1.000

3.  [Ankle arthrodesis with an posterolateral approach using a polyaxial angle stable Talarlock® plate].

Authors:  N Gutteck; S Lebek; A Zeh; G Gradl; K-S Delank; D Wohlrab
Journal:  Oper Orthop Traumatol       Date:  2013-12-06       Impact factor: 1.154

4.  A modified and enhanced test setup for biomechanical investigations of the hindfoot, for example in tibiotalocalcaneal arthrodesis.

Authors:  Julia Evers; Martin Schulze; Dominic Gehweiler; Martin Lakemeier; Michael J Raschke; Dirk Wähnert; Sabine Ochman
Journal:  BMC Musculoskelet Disord       Date:  2016-07-29       Impact factor: 2.362

5.  Ankle arthrodesis using a retrograde intramedullary rod with fins for highly destructive joints in elderly patients with rheumatoid arthritis: A report of two cases.

Authors:  Shun Takahashi; Naoki Kondo; Yasufumi Kijima; Rika Kakutani; Hajime Ishikawa; Hiroyuki Kawashima
Journal:  Clin Case Rep       Date:  2022-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.